Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ascendis Pharma A (ASND) Other Non-Current Liabilities (2019 - 2020)

Ascendis Pharma A's Other Non-Current Liabilities history spans 2 years, with the latest figure at $3.8 million for Q4 2020.

  • For Q4 2020, Other Non-Current Liabilities rose 275.11% year-over-year to $3.8 million; the TTM value through Dec 2020 reached $3.8 million, up 275.11%, while the annual FY2020 figure was $3.8 million, 270.74% up from the prior year.
  • Other Non-Current Liabilities for Q4 2020 was $3.8 million at Ascendis Pharma A, up from $1.0 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $3.8 million in Q4 2020 and bottomed at $1.0 million in Q4 2019.